Overview
Takayuki Shimose practices in Higashi, Japan. Mr. Shimose is rated as an Experienced expert by MediFind in the treatment of Chronic Myelogenous Leukemia (CML). His top areas of expertise are Small Cell Lung Cancer (SCLC), Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), EGFR Positive Lung Cancer, and Tissue Biopsy.
His clinical research consists of co-authoring 30 peer reviewed articles. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Chronic Myelogenous Leukemia (CML).
Locations
Clinical Research
Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.
Areas of Expertise
MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.
Learn more about MediFind’s expert tiers
- Experienced
- AgranulocytosisMr. Shimose isExperienced. Learn about Agranulocytosis.
- Chronic Myelogenous Leukemia (CML)Mr. Shimose isExperienced. Learn about Chronic Myelogenous Leukemia (CML).
- Colorectal CancerMr. Shimose isExperienced. Learn about Colorectal Cancer.
- EGFR Positive Lung CancerMr. Shimose isExperienced. Learn about EGFR Positive Lung Cancer.
- Febrile NeutropeniaMr. Shimose isExperienced. Learn about Febrile Neutropenia.
- Lung CancerMr. Shimose isExperienced. Learn about Lung Cancer.